BACKGROUND
• Atopic dermatitis (AD) is a chronic, itchy, inflammatory skin disorder that affects both children and adults.
• Overall, AD affects approximately 15% to 30% of children and 2% to 10% of adults.
1
• Prevalence is higher, and on the rise, in industrial nations, 2, 3 and varies by age group and geographic region. 1, 4, 5 However, ranges for these demographic characteristics may vary between countries.
• Emphasis on patient-focused drug development has increased interest in capturing the patient voice. Where patient input cannot be reported, caregiver input may be used.
• Since AD affects children and adults, both observer-and patient-reported outcomes (ObsROs and PROs, respectively) need to be considered in the assessment of the condition.
CONCLUSION
• Based on the literature, AD-related concepts include signs/symptoms and associated impacts (ie, functional, emotional, social).
• The identified PRO and ObsRO measures were primarily developed for research purposes, as opposed to making regulatory decisions.
• While existing PRO and ObsRO measures include some of these AD concepts, the quality of the measures was not assessed.
• There appears to be a lack of comprehensive AD-specific measures, and future research should focus on a gap analysis. 
METHODS
• A targeted search of the literature was conducted using Embase, Patient-Reported Outcome and Quality of Life Instruments Database (PROQolid), and PubMed to identify PRO and ObsRO measures that assess ADrelated signs/symptoms and associated impacts.
-Key words used in the searches included "atopic dermatitis"; "patient-reported outcomes"; "signs"; "symptoms"; "impact"; "observer-reported outcomes" • Abstracts were retrieved and screened to identify potentially relevant articles.
• Relevant articles were then retrieved and reviewed in full for signs, symptoms, and impacts, as well as outcome measures assessing these domains. • These concepts were organized into a conceptual model, and identified measures were evaluated to classify concepts assessed by each measure.
RESULTS

Signs, Symptoms, and Impacts Conceptual Model
• Based on literature, AD-related concepts included signs/symptoms, functional impacts, emotional impacts, and social impacts.
• Figure 1 presents the literature-based conceptual model developed in order to summarize these concepts.
• The most commonly found sub-concepts for signs/symptoms of AD were itching, skin dryness, and skin thickening.
• Impact on daily activity, trouble sleeping, and avoidance of specific hobbies were the most commonly reported sub-concepts under functional impacts.
• Frustration, embarrassment, and reduced self-esteem/self-confidence were common emotional impacts.
• Isolation, low social integration, as well as a negative effect on work/school performance and engagement were frequently reported as social impacts.
Patient-and Observer-Reported Outcome Measures
• A total of 9 PRO and ObsRO measures for use in pediatrics (n=2), adults (n=6), as well as both pediatrics and adults (n=1), were identified and reviewed ( Table 1) .
• Of the 9 dermatology-specific measures that were identified, only 1 (the Quality of Life Index for Atopic Dermatitis [QoLIAD]) was specific to AD.
• The QoLIAD evaluates 9 sub-concepts, which represents 27% of the literature-based concepts, while the Dermatology-Specific
Quality of Life Instrument (DSQL) for Contact
Dermatitis evaluates 18 sub-concepts, which represents 55% of the literature-based concepts that were identified.
-While the DSQL evaluated more literaturebased concepts that were relevant to AD, it is important to note that it is not an ADspecific measure. 
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